Abstract:Various heteroaryl and bicyclo-aliphatic analogues of zwitterionic biaryl P2Y14 receptor (P2Y14R) antagonists were synthesized, and affinity was measured in P2Y14R-expressing Chinese hamster ovary cells by flow cytometry. Given this series' low water solubility, various polyethylene glycol derivatives of the distally binding piperidin-4-yl moiety of moderate affinity were synthesized. Rotation of previously identified 1,2,3-triazole attached to the central m-benzoic acid core (25) provided moderate affinity but not indole and benzimidazole substitution of the aryl-triazole. The corresponding P2Y14R region is predicted by homology modeling as a deep, sterically limited hydrophobic pocket, with the outward pointing piperidine moiety being the most flexible. Bicyclic-substituted piperidine ring derivatives of naphthalene antagonist 1, e.g., quinuclidine 17 (MRS4608, IC50 ≈ 20 nM at hP2Y14R/mP2Y14R), or of triazole 2, preserved affinity. Potent antagonists 1, 7a, 17, and 23 (10 mg/kg) protected in an ovalbumin/Aspergillus mouse asthma model, and PEG conjugate 12 reduced chronic pain. Thus, we expanded P2Y14R antagonist structure–activity relationship, introducing diverse physical–chemical properties.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00745?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00745</a>.Synthesis of additional compounds (4-bromophenyl intermediates and carboxylate substitutions on the central phenyl ring of 2); off-target binding inhibition curves; pharmacological data; molecular modeling data, including docking poses of selected compounds, number of contacts between the receptor residues and the ligand in each MD replicate, RMSD and ligand–receptor interaction pattern during MD replicate 3, RMSD and ligand-receptor interaction pattern during MD replicate 4, and analysis of MD replicates; predicted pharmacokinetic parameters; predicted log D and log S; and methods to measure solubility and lipohilicity (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_001.pdf">PDF</a>)NMR and mass spectra of final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_006.pdf">PDF</a>)3D coordinates of hP2Y14R in complex with 17, obtained through molecular docking (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_002.pdb">PDB</a>)MD trajectory (replicate 3) of the complex between compound 17 and hP2Y14R, after alignment of the receptor Cα atoms to the initial frame (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_003.mp4">MP4</a>)MD trajectory (replicate 4) of the complex between compound 17 and hP2Y14R, after alignment of the receptor Cα atoms to the initial frame (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_004.mp4">MP4</a>)Molecular formula strings of P2Y14R antagonists (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_005.pdf">PDF</a>)This article has not yet been cited by other publications.

2,5-Disubstituted Pyridines As Potent Gpr119 Agonists

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Design, Synthesis and Biological Evaluation of Novel Pyrimidinedione Derivatives As DPP-4 Inhibitors.

Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists

Discovery of 3-((4-benzylpyridin-2-yl)amino)benzamide Derivatives as Potent GPR52 G Protein-Biased Agonists.

Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists

Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors

The development of diphenyleneiodonium analogs as GPR3 agonists

Discovery of a 4-Aryloxy-1h-pyrrolo[3,2-c]pyridine and a 1-Aryloxyisoquinoline Series of TRPA1 Antagonists

Discovery, Cocrystallization and Biological Evaluation of Novel Piperidine Derivatives As High Affinity Ls-AChBP Ligands Possessing Α7 Nachr Activities.

Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics.

Discovery of N-Substituted Acetamide Derivatives as Promising P2Y 14 R Antagonists Using Molecular Hybridization Based on Crystallographic Overlay

Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold.

Exploration of Alternative Scaffolds for P2Y 14 Receptor Antagonists Containing a Biaryl Core

Design, synthesis and evaluation of 3-phenoxypyrazine-2-carboxamide derivatives as potent TGR5 agonists

Discovery and structure - activity relationships of 2,4,5-trimethoxyphenyl pyrimidine derivatives as selective D5 receptor partial agonists

Structure-Activity Relationship Studies and Optimization of 4-Hydroxypyridones as GPR84 Agonists

Design, Synthesis and Computational Insight of Isolated and Thiophene fused 2H‐Pyran‐2‐ones as PPAR‐γ Agonist

Design, Synthesis and SAR Exploration of Alkyl/PhenylalkylPiperidine Analogues As Novel Highly Potent and Selective MOR Agonists.

Novel piperazine urea derivatives as highly potent transient receptor potential vanilloid 1 (TRPV1) antagonists

Design, Synthesis, and in Vitro Bioactivity Evaluation of Fluorine-Containing Analogues for Sphingosine-1-phosphate 2 Receptor.